Abstract
We report the successful treatment with linezolid of a methicillin-resistant Staphylococcus aureus (MRSA) endocarditis in a patient with a severe allergic reaction to glycopeptides. Linezolid is a drug with well-recognised activity against S. aureus and proved to be efficacious even in the unusual site of heart valves. This drug could be a good therapeutic choice when glycopeptides treatment is not feasible.
MeSH terms
-
Acetamides / therapeutic use*
-
Anti-Infective Agents / therapeutic use*
-
Endocarditis, Bacterial / drug therapy*
-
Endocarditis, Bacterial / microbiology
-
Humans
-
Linezolid
-
Methicillin Resistance*
-
Oxazolidinones / therapeutic use*
-
Staphylococcal Infections / drug therapy*
-
Staphylococcal Infections / microbiology
-
Staphylococcus aureus / drug effects*
-
Staphylococcus aureus / isolation & purification
Substances
-
Acetamides
-
Anti-Infective Agents
-
Oxazolidinones
-
Linezolid